With Sean and Nina gone, Skiip has Aortic on the chopping blocks to support his other M&A plans. All the dots are connecting... Skiip (whose only expertise throughout his career is divestures and acquisitions) is brought to CV OU. Sean, and then Nina depart. No significant investments in Aortic for past several years. Market share and net profit from Aortic are declining. It's not if, it's when... or rather how soon!
8 replies (most recent on top)
Get back to work, but first get your head examined.
@ke Groundbreaking.
@e1 most recent change is to update the handle shell.
God tier R&D......
The question is, what else would skip acquire in that division?
Is this a surprise?
What was the last new product aortic specific product released? Endurant II? That was 13 years ago. The Aortic facility in Santa Rosa closed years ago. As far as I can tell, there were 2 people working on continuing R&D efforts for Aortic in Santa Rosa.
Aortic and surgical structural heart (whatever Medtronic call metal and tissue valves now) are For Sale. But have been for more than 1 year.
No buyers.
@bf absolutely nothing.
What had Skiip accomplished at his previous post with CST?